DB
DBV Technologies S.A.
DBVT · NASDAQ
$12.35 -1.91% (-$0.24)
1M -13.27%
Market Cap $299.3M
P/E Ratio -
Div. Yield -
ROE 119.23%
Bulios Fair Price
$12.17
1.5% downside
Current Price
$12.35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DBVT is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
91 /100
Cheap P/B 1.87x
EV/EBITDA N/A
P/S N/A
Growth
2 /100
Declining Book val. growth 4.61%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 119.23%
ROA 78.78%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 3.72x
Debt/Equity 0.13x
Net debt/EBITDA N/A
Stability
33 /100
Unstable EPS volatility 53.24%
Profitable years 0
Beta -0.21x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DBVT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel Tassé
Employees
161
Headquarters
Châtillon
Upcoming events
28 OCT
Earnings
Upcoming earnings report